[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.212.130. Please contact the publisher to request reinstatement.
Article
June 1958

Homologous Marrow Transplantation in Rabbits After Triethylenethiophosphoramide

Author Affiliations

Boston
From the Laboratories for Surgical Research, Harvard Medical School and Peter Bent Brigham Hospital.; Joint British Postgraduate Medical Federation Travelling Fellow and George Gorham Peters Fellow (Dr. Porter); present address: Department of Pathology, St. Mary's Hospital, Paddington, London, W. 2. Associate in Surgery (Plastic Surgery) Peter Bent Brigham Hospital; Clinical Associate in Surgery, Harvard Medical School (Dr. Murray).

AMA Arch Surg. 1958;76(6):908-911. doi:10.1001/archsurg.1958.01280240066010
Abstract

Triethylenethiophosphoramide ( T h i o-TEPA), the sulfur derivative of triethylenephosphoramide, has been found to be active in preventing metastases of rat mammary adenocarcinoma.1 Clinically, temporary regression of human breast carcinoma has also been obtained,2-4 this drug being one of the few so far discovered with a definite effect on malignant epithelial tumors. However, bone-marrow depression, especially in patients with osseous metastases, has been encountered as a serious toxic effect, limiting the dosage which can be employed.

When marrow aplasia occurs in animals after exposure of the whole body to x-rays, the process can be reversed in some instances by an intravenous injection of homologous myeloid cells, the depleted blood-forming tissues being colonized by cells derived from those which have been injected.5

The present experiments were therefore undertaken to determine whether homologous * marrow would similarly implant any proliferate when infused into rabbits which had received marrow-depressant doses of

×